Stocks to Buy: Four Stocks to Consider on (3/29/16)

MIAMI, FL / ACCESSWIRE / March 28, 2016 / Top Nasdaq Stocks is issuing a report on four stocks to watch. RJETQ, COOL, KERX, and CTRV have been added to our watch list today. Continue reading to find out why. – To get daily alerts on top stocks on the Nasdaq/NYSE subscribe to our newsletter at TopNasdaqStocks.com.

Republic Airways Holdings Inc. (OTC: RJETQ) has seen an increase in price and volume during early trading on Tuesday morning (3/29). The bankrupt airline has been making headlines recently after the company made several announcements including reaching a deal to unload the leases on more than two dozen aircraft. Further, last week the lawsuit by Delta was dropped against the airline and further, reports show that Delta will provide $75 million in credit to help Republic rebuild under bankruptcy protection.

Stay Informed and Up To Date On The Hottest NASDAQ Plays. Get Them Here

Majesco Entertainment Co. (NASDAQ: COOL)has seen a test of its near 3-month highs. Monday morning the stock saw price increase to as much as 0.9899 per share. Last week the stock tested the same level having hit highs of 0.99 on Tuesday March 22. Majesco Entertainment Company is an innovative developer, marketer, publisher and distributor of interactive entertainment for consumers around the world. Majesco develops and publishes a wide range of video games on digital networks through its Midnight City label.

Members of record by 4PM March 29 (today) will secure a place holder to receive our next report. Get Your Free Membership Now.

Keryx Biopharmaceuticals Inc. (NASDAQ: KERX) announced today (3/29) that it recorded positive top-line results for its pivotal 24-week Phase 3 study of ferric citrate, an oral, iron-based medicine in development for the treatment of iron deficiency anemia in adults with stage 3-5 non-dialysis dependent chronic kidney disease. This stock has gained a place on the most mentions list on social media today as the stock opened at $5.58 and saw early highs of $5.74 on more than ten times the amount of shares traded on Monday 3/28.

Enjoy picks like this? Get These Alerts and More on NASDAQ Companies before They Rally, Text the word “NASDAQ” to 77948

ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV) today (3/29) reported positive results from a third-party in vitro study that further validates CMX157’s profile as a highly potent anti-hepatitis B drug. Shares of CTRV have climbed more than 35% in early trading as compared to its previous close. Volume has also remained well above average following this announcement.

Stay Informed and Up To Date On The Hottest NASDAQ Plays. Get Them Here

About TopNasdaqStocks.com

Looking for stock market and business news headlines? How about up to the minute information on mutual funds and ETFs? Don’t forget about the top stock picks of 2016. TopNasdaqStocks.com has it all. Make sure to subscribe to our free newsletter and to receive free text message alerts on your phone, text “NASDAQ” to 77948.

Disclosure: The information, opinions and analysis contained in this report are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We do not accept any responsibility or liability for any losses, damages or costs arising from an investor’s or other person’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities, nor a recommendation of any security. Past gains are not representative of future gains. Pursuant to an agreement between us and a non affiliate 3rd party we were hired for a period beginning on 3/20/16 and ending on 6/19/16 to publicly disseminate information about (cool) including on the website and other media including facebook and twitter. We are being paid $100,000 (cash) for or were paid “zero” shares of unrestricted or restricted common shares. We own zero shares of (cool), which we purchased in the open market. We plan to sell the “zero” shares of (cool) that we hold during the time the website and/or facebook and twitter information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (cool) in the open market at any time, including before, during or after the website and information, provide public dissemination of favorable information. Top Nasdaq Stocks has not been compensated nor does it expect to receive any compensation for distribution of its opinions and publicly available information regarding KERX, CTRV, or RJETQ in this investment opinion article at this time. The opinions contained herein contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. When used herein, the words “anticipate,” “intend,” “estimate,” “believe,” “expect,” “plans,” “should,” “potential,” “forecast,” and variations of such words and similar expressions are intended to identify forward-looking statements. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A company’s actual results could differ materially from those described in any forward-looking statements contained herein. Top Nasdaq Stocks is not a licensed broker, broker dealer, market maker, investment advisor, analyst or underwriter. We recommend that you use the information found herein as an initial starting point for conducting your own research in order to determine your own personal opinion of the companies discussed herein before deciding whether or not to invest. You should seek such investment, tax, financial, accounting or legal advice appropriate for your particular circumstances. Information about many publicly traded companies and other investor resources can be found at www.sec.gov. Investing in securities is speculative and carries risk. Please visit http://topnasdaqstocks.com/index.php/disclaimer/ website for a more detailed discussion of risks and disclosures

Contact:

Top Nasdaq Stocks
news@topnasdaqstocks.com

SOURCE: Top Nasdaq Stocks

ReleaseID: 438244